Literature DB >> 20873997

Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.

Claus Wittekindt1, Nebojsa Jovanovic, Orlando Guntinas-Lichius.   

Abstract

CONCLUSION: In this study we found that inflammatory cells may be a source of MMP-9 in laryngeal cancer. MMP-9 was correlated with blood vessel density. MMP-9 may be a potential target to disrupt tumor neovascularization.
OBJECTIVE: To study the expression of MMP-9 in laryngeal cancer and determine a possible relation with blood vessel density.
METHODS: Immunohistochemistry was used for MMP analysis and for blood vessel detection in 83 laryngeal cancer samples. The density of blood vessels was analyzed with a stereological tool.
RESULTS: MMP-9 was detected in inflammatory cells. Positivity for MMP-9 correlated significantly with the grade of differentiation (p = 0.025). Expression of MMP-9 was not correlated with T stage, nodal metastasis, or tumor recurrence. The mean blood vessel density was 51.4 vessels/mm². Specimens were more likely to exhibit higher density of blood vessels when MMP-9 expression was also present (p = 0.014).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20873997     DOI: 10.3109/00016489.2010.506886

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance.

Authors:  Bin-Quan Wang; Chun-Ming Zhang; Wei Gao; Xu-Feng Wang; Hai-Li Zhang; Ping-Chang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-11       Impact factor: 4.553

2.  Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.

Authors:  Hyereen Kang; Sung-Wuk Jang; Jesang Ko
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

3.  Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.

Authors:  Sharat C Raju; Samantha J Hauff; Aaron J Lemieux; Ryan K Orosco; Andrew M Gross; Linda T Nguyen; Elamprakash Savariar; William Moss; Michael Whitney; Ezra E Cohen; Scott M Lippman; Roger Y Tsien; Trey Ideker; Sunil J Advani; Quyen T Nguyen
Journal:  Oral Oncol       Date:  2015-02-27       Impact factor: 5.337

4.  Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.

Authors:  Dina V Hingorani; Aaron J Lemieux; Joseph R Acevedo; Heather L Glasgow; Suraj Kedarisetty; Michael A Whitney; Alfredo A Molinolo; Roger Y Tsien; Quyen T Nguyen
Journal:  Oral Oncol       Date:  2017-06-27       Impact factor: 5.337

5.  Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.

Authors:  Samantha J Hauff; Sharat C Raju; Ryan K Orosco; Andrew M Gross; Julio A Diaz-Perez; Elamprakash Savariar; Nadia Nashi; Jonathan Hasselman; Michael Whitney; Jeffrey N Myers; Scott M Lippman; Roger Y Tsien; Trey Ideker; Quyen T Nguyen
Journal:  Otolaryngol Head Neck Surg       Date:  2014-08-04       Impact factor: 3.497

6.  Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.

Authors:  Vykintas Liutkevicius; Vaiva Lesauskaite; Rasa Liutkeviciene; Paulius Vaiciulis; Virgilijus Uloza
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

7.  Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

Authors:  Elamprakash N Savariar; Csilla N Felsen; Nadia Nashi; Tao Jiang; Lesley G Ellies; Paul Steinbach; Roger Y Tsien; Quyen T Nguyen
Journal:  Cancer Res       Date:  2012-11-27       Impact factor: 12.701

8.  Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions.

Authors:  Virgilijus Uloza; Vykintas Liutkevicius; Dalia Pangonyte; Vaiva Lesauskaite
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-02-03       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.